INVESTMENTS

Novo Nordisk (NVO / NOVO-B.CO) has faced a brutal 2025, with shares down over 50% year-to-date, currently trading around $50.63. The once high-flying GLP-1 leader is reeling from pricing challenges, slowing growth, and fierce competition from Eli Lilly’s tirzepatide portfolio. However, pipeline optimism remains: higher-dose Wegovy gained EMA support, Ozempic launched in India at scale, and the $4.7B Akero deal enhances its cardiometabolic pipeline. As of December 15, 2025, Novo Nordisk stock is up 0.9% intraday, as investors recalibrate long-term potential amid sector-wide valuation resets.

Empresas Lipigas S.A. (BCS:LIPIGAS), a top-tier LPG and natural gas distributor in Latin America, is trading near historic highs as of December 15, 2025. The stock has soared over 100% in 2025 alone, now hovering around CLP 8,526, driven by strong earnings, regional growth, and a new interim dividend. Its acquisition in Ecuador and continued dominance in Chile, Peru, and Colombia are reshaping its image from a sleepy utility into a resilient growth play. The upcoming dividend (CLP 153/share, ex-date: Dec 21) is prompting more buying as investors seek exposure to one of the most defensive and rewarding names on the Santiago Stock Exchange. This article unpacks the latest catalysts, trends, and outlook for Lipigas.

Oracle (NYSE: ORCL) is currently navigating one of its most volatile periods in recent memory. Despite reporting record-breaking Q2 FY2026 earnings, the stock has dropped sharply, reflecting deep investor concern over high capital expenditures, debt levels, and uncertainty around AI infrastructure execution. As of 15 December 2025, shares are trading around $185.58—down 2.31% on the day and nearly 45% off their September highs. What's driving this paradox? A mix of bullish fundamentals—like a $523 billion backlog—and bearish fears surrounding delayed OpenAI projects, spiralling Capex, and tightening credit markets. This article unpacks what’s really happening with Oracle stock today and where it might be headed next.

November 2025 was a nasty wake-up call for bitcoin bulls. After a euphoric October that pushed BTC to a record near $126,000, the market flipped into full correction mode: price slid from the $109,000-$115,000 consolidation range to lows around $80,500, ETF flows turned sharply negative, and a wave of institutional de-risking and leveraged liquidations crushed sentiment into "extreme fear." By late month, a modest rebound toward the high-$80,000s emerged as ETF outflows eased and traders started to price in a possible Fed rate cut. This overview explains the timeline, the ETF and macro forces behind the dump, and what levels and scenarios serious investors are watching next.